151 related articles for article (PubMed ID: 20225242)
41. Heparin-binding EGF-like growth factor mRNA is upregulated in the peri-infarct region of the remnant kidney model: in vitro evidence suggests a regulatory role in myofibroblast transformation.
Kirkland G; Paizis K; Wu LL; Katerelos M; Power DA
J Am Soc Nephrol; 1998 Aug; 9(8):1464-73. PubMed ID: 9697669
[TBL] [Abstract][Full Text] [Related]
42. Heparin-binding epidermal growth factor-like growth factor protects rat intestine after portal triad clamping.
Liao X; Chen L; Fu W; Zhou J
Growth Factors; 2013 Apr; 31(2):74-80. PubMed ID: 23534509
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis.
Khong TF; Fraser S; Katerelos M; Paizis K; Hill PA; Power DA
Kidney Int; 2000 Sep; 58(3):1098-107. PubMed ID: 10972674
[TBL] [Abstract][Full Text] [Related]
44. Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell- and region-specific manner and acts to inhibit apoptosis.
Nguyen HT; Bride SH; Badawy AB; Adam RM; Lin J; Orsola A; Guthrie PD; Freeman MR; Peters CA
Am J Pathol; 2000 Mar; 156(3):889-98. PubMed ID: 10702406
[TBL] [Abstract][Full Text] [Related]
45. Heparin-binding epidermal growth factor-like growth factor is expressed in the adhesive lesions of experimental focal glomerular sclerosis.
Paizis K; Kirkland G; Khong T; Katerelos M; Fraser S; Kanellis J; Power DA
Kidney Int; 1999 Jun; 55(6):2310-21. PubMed ID: 10354279
[TBL] [Abstract][Full Text] [Related]
46. Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation.
Celie JW; Katta KK; Adepu S; Melenhorst WB; Reijmers RM; Slot EM; Beelen RH; Spaargaren M; Ploeg RJ; Navis G; van der Heide JJ; van Dijk MC; van Goor H; van den Born J
Kidney Int; 2012 Apr; 81(7):651-61. PubMed ID: 22237752
[TBL] [Abstract][Full Text] [Related]
47. Nicorandil protects against ischaemia-reperfusion injury in newborn rat kidney.
Zhang YJ; Zhang AQ; Zhao XX; Tian ZL; Yao L
Pharmacology; 2013; 92(5-6):245-56. PubMed ID: 24247737
[TBL] [Abstract][Full Text] [Related]
48. Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo.
Kuhn MA; Xia G; Mehta VB; Glenn S; Michalsky MP; Besner GE
Antioxid Redox Signal; 2002 Aug; 4(4):639-46. PubMed ID: 12230876
[TBL] [Abstract][Full Text] [Related]
49. Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.
Miyazawa T; Zeng F; Wang S; Fan X; Cheng H; Yang H; Bian A; Fogo AB; Harris RC
Kidney Int; 2013 Dec; 84(6):1176-88. PubMed ID: 23760291
[TBL] [Abstract][Full Text] [Related]
50. ADAM19 expression in human nephrogenesis and renal disease: associations with clinical and structural deterioration.
Melenhorst WB; van den Heuvel MC; Timmer A; Huitema S; Bulthuis M; Timens W; van Goor H
Kidney Int; 2006 Oct; 70(7):1269-78. PubMed ID: 16900093
[TBL] [Abstract][Full Text] [Related]
51. High expression of heparin-binding EGF-like growth factor in rat hepatocarcinogenesis.
Miyoshi E; Higashiyama S; Nakagawa T; Suzuki K; Horimoto M; Hayashi N; Fusamoto H; Kamada T; Taniguchi N
Int J Cancer; 1996 Oct; 68(2):215-8. PubMed ID: 8900431
[TBL] [Abstract][Full Text] [Related]
52. Transient Receptor Potential Vanilloid 4 Channel Deficiency Aggravates Tubular Damage after Acute Renal Ischaemia Reperfusion.
Mannaa M; Markó L; Balogh A; Vigolo E; N'diaye G; Kaßmann M; Michalick L; Weichelt U; Schmidt-Ott KM; Liedtke WB; Huang Y; Müller DN; Kuebler WM; Gollasch M
Sci Rep; 2018 Mar; 8(1):4878. PubMed ID: 29559678
[TBL] [Abstract][Full Text] [Related]
53. Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats.
Feng L; Garcia GE; Yang Y; Xia Y; Gabbai FB; Peterson OW; Abraham JA; Blantz RC; Wilson CB
J Clin Invest; 2000 Feb; 105(3):341-50. PubMed ID: 10675360
[TBL] [Abstract][Full Text] [Related]
54. Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury.
Guo J; Guan Q; Liu X; Wang H; Gleave ME; Nguan CY; Du C
BMC Nephrol; 2016 Sep; 17(1):133. PubMed ID: 27649757
[TBL] [Abstract][Full Text] [Related]
55. Effects of combined erythropoietin and epidermal growth factor on renal ischaemia/reperfusion injury: a randomized experimental controlled study.
Hussein Ael-A; Shokeir AA; Sarhan ME; El-Menabawy FR; Abd-Elmoneim HA; El-Nashar EM; Barakat NM
BJU Int; 2011 Jan; 107(2):323-8. PubMed ID: 20346036
[TBL] [Abstract][Full Text] [Related]
56. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells.
Day YJ; Huang L; McDuffie MJ; Rosin DL; Ye H; Chen JF; Schwarzschild MA; Fink JS; Linden J; Okusa MD
J Clin Invest; 2003 Sep; 112(6):883-91. PubMed ID: 12975473
[TBL] [Abstract][Full Text] [Related]
57. Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury.
Sonoda H; Yokota-Ikeda N; Oshikawa S; Kanno Y; Yoshinaga K; Uchida K; Ueda Y; Kimiya K; Uezono S; Ueda A; Ito K; Ikeda M
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1006-16. PubMed ID: 19640902
[TBL] [Abstract][Full Text] [Related]
58. Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice.
El-Assal ON; Paddock H; Marquez A; Besner GE
J Pediatr Surg; 2008 Jun; 43(6):1182-90. PubMed ID: 18558204
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of hyaluronan is protective against renal ischaemia-reperfusion injury.
Colombaro V; Declèves AE; Jadot I; Voisin V; Giordano L; Habsch I; Nonclercq D; Flamion B; Caron N
Nephrol Dial Transplant; 2013 Oct; 28(10):2484-93. PubMed ID: 24078641
[TBL] [Abstract][Full Text] [Related]
60. Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury.
Xia G; Martin AE; Michalsky MP; Besner GE
J Pediatr Surg; 2002 Jul; 37(7):1081-7; discussion 1081-7. PubMed ID: 12077776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
